.png)
.png)
Loading Shopping Cart Items...
Catalog
Book
Added:05/30/2023 10:30 AM
New Poster!!
Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography June 2022
Poster Size is 24 x 30
PLEASE NOTICE: This is a Physical Product. A shipping and handling fee will be added to your shopping cart at check-out.
Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography June 2022
Poster Size is 24 x 30
PLEASE NOTICE: This is a Physical Product. A shipping and handling fee will be added to your shopping cart at check-out.
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
$35.00
Already successfully completed: re-enrollment available!
Secure Transaction
Recently Added Items
About this item
New Poster!!
Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography June 2022
Poster Size is 24 x 30
PLEASE NOTICE: This is a Physical Product. A shipping and handling fee will be added to your shopping cart at check-out.
Course/Activity Information
Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic mechanisms including left ventricular outflow tract obstruction with or without significant mitral regurgitation, diastolic dysfunction with heart failure with preserved and heart failure with reduced ejection fraction, autonomic dysfunction, ischemia, and arrhythmias.
Ratings and reviews
Type:
Name:
Sub type:
Value: